Quarterly report · Q2
2689.TEDINET S100SVKV
Period2023-07-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥57.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥110.5bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥53.7bn | 2022-07-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥747m | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥854m | 2022-07-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥746m | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥859m | 2022-07-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥745m | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥857m | 2022-07-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥486m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥548m | 2022-07-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥486m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥548m | 2022-07-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥43.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥40.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥40.6bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.3bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥30.6bn | at 2023-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥10.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥9.3bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.9bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2022-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥146m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥660m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.9bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥347m | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥306m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥143m | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.0bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥176m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥81.01 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.16 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥234.9 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.09 | 2022-07-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.24 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 23.4% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.3% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.9% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥725m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥725m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥76m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥1m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥102m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥54.3bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥53.6bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥656m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥669m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥2.6bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥2.5bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥68m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥52m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥58.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥57.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥725m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥823m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-12-31 | −¥789m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-12-31 | −¥789m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-12-31 | −¥71m |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥104,000 |
| jpcrp040300-q2r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥92m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥50.7bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥50.0bn |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥726m |
| jpcrp040300-q2r_E02928-000Medical Equipmentreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥735m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥2.6bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥2.5bn |
| jpcrp040300-q2r_E02928-000SPDreportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥64m |
| jpcrp040300-q2r_E02928-000SPDreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥98m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2022-12-31 | ¥54.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2022-12-31 | ¥53.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥789m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2022-12-31 | ¥925m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)神 田 正 史 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)鈴 木 重 久 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 53718093000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 57466305000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 110472640000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 859330000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 746138000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 2158041000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 547668000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 486066000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1414238000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 531883000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 478798000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1561779000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 9277235000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 10155291000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 10327643000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 40562264000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 43446880000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 40878181000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 91.09 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 81.01 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 234.90 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.229 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.234 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.253 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | -1934375000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -145555000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -659519000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -142937000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -347169000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -306247000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 1534033000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 1014382000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 175938000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 2606325000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 2881434000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 2359777000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 49.24 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 53.16 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 6250000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 6250000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 6250000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 6250000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |